Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-003594

Chief Operating Officer sold 2,234 shares at $6.15 ($13,744)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bertrand William C JR Chief Operating Officer 2021-01-12 Sale −2,234 $6.15 $13,744 3,768 D
Open-market sales · 2,234 sh · avg $6.15 · $13,744
Loading xslF345X03/tm212950-4_4seq1.xml…